×

Register now for full access to all the content

First Name
Last Name
Company
Title
Country
Thank you for registering!
Error - something went wrong!
   

Building Value With Real-World Data

August 22, 2017

Real world evidence tailored to meet the specific needs of a range of reimbursement agencies is essential to help strengthen the value message in your new drug submissions.

There are many different Health Technology Assessment agencies around the world who all have very different standards for granting approvals, each placing differing levels of emphasis on different factors. These differences can sometimes reduce the return a company would usually expect to receive. 
 

To avoid this, there are two important steps pharmaceutical development companies can take: 

1. Assess of the need for the drug in accordance with the requirements of each individual agency 
2. Support key messages by gathering the evidence you will need.

Previous Flipbook
Market Access Data: Fuel for Successful Product Launches
Market Access Data: Fuel for Successful Product Launches

Learn more about commercialization and market access here!

Next Flipbook
More Options and Challenges: Bringing Drugs To Market Early
More Options and Challenges: Bringing Drugs To Market Early

Read this article to learn more about bringing drugs to market early!